Cargando…
Melanie Saville: the end-to-end process needed for a SARS-CoV-2 vaccine
Melanie Saville talks to Gary Humphreys about the specific challenges faced in developing and distributing SARS-CoV-2 vaccines and the need to fund end-to-end approaches to support those aims.
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
World Health Organization
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7463193/ https://www.ncbi.nlm.nih.gov/pubmed/33012858 http://dx.doi.org/10.2471/BLT.20.030920 |
| _version_ | 1783577078843572224 |
|---|---|
| collection | PubMed |
| description | Melanie Saville talks to Gary Humphreys about the specific challenges faced in developing and distributing SARS-CoV-2 vaccines and the need to fund end-to-end approaches to support those aims. |
| format | Online Article Text |
| id | pubmed-7463193 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | World Health Organization |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-74631932020-10-02 Melanie Saville: the end-to-end process needed for a SARS-CoV-2 vaccine Bull World Health Organ News Melanie Saville talks to Gary Humphreys about the specific challenges faced in developing and distributing SARS-CoV-2 vaccines and the need to fund end-to-end approaches to support those aims. World Health Organization 2020-09-01 2020-09-01 /pmc/articles/PMC7463193/ /pubmed/33012858 http://dx.doi.org/10.2471/BLT.20.030920 Text en (c) 2020 The authors; licensee World Health Organization. This is an open access article distributed under the terms of the Creative Commons Attribution IGO License (http://creativecommons.org/licenses/by/3.0/igo/legalcode), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. In any reproduction of this article there should not be any suggestion that WHO or this article endorse any specific organization or products. The use of the WHO logo is not permitted. This notice should be preserved along with the article's original URL. |
| spellingShingle | News Melanie Saville: the end-to-end process needed for a SARS-CoV-2 vaccine |
| title | Melanie Saville: the end-to-end process needed for a SARS-CoV-2 vaccine |
| title_full | Melanie Saville: the end-to-end process needed for a SARS-CoV-2 vaccine |
| title_fullStr | Melanie Saville: the end-to-end process needed for a SARS-CoV-2 vaccine |
| title_full_unstemmed | Melanie Saville: the end-to-end process needed for a SARS-CoV-2 vaccine |
| title_short | Melanie Saville: the end-to-end process needed for a SARS-CoV-2 vaccine |
| title_sort | melanie saville: the end-to-end process needed for a sars-cov-2 vaccine |
| topic | News |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7463193/ https://www.ncbi.nlm.nih.gov/pubmed/33012858 http://dx.doi.org/10.2471/BLT.20.030920 |